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http://dx.doi.org/10.1016/j.kjms.201Abstract The prevalence of allergic diseases has increased in recent decades. Allergic
diseases, particularly asthma, are complex diseases with strong gene-environment interac-
tions. Epidemiological studies have identified a variety of risk factors for the development
of allergic diseases. Among them, endocrine-disrupting chemicals (EDCs) play an important
role in triggering or exacerbating these diseases. 4-Nonylphenol (NP) and 4-octylphenol
(OP)dtwo major alkylphenolsdhave been recognized as common toxic and xenobiotic endo-
crine disrupters. Due to their low solubility, high hydrophobicity, and low estrogenic activity,
they tend to accumulate in the human body and may be associated with the adverse effects of
allergic diseases. Recently, new evidence has supported the importance of alkylphenols in the
in vitro allergic response. This review focuses on the effects of alkylphenols on several key cell
types in the context of allergic inflammation.
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In recent decades, the prevalence of allergic diseases has
steadily increased worldwide [1]. Although many studies
suggest that genetic variation strongly affects suscepti-
bility, exposure to environmental factors, such as
endocrine-disrupting chemicals (EDCs), clearly influences
the onset, progression, and severity of these diseases [2].ed.
S44 J.-L. Suen et al.Thus, gene-environment interactions are curial for the
pathogenesis of allergic diseases such as asthma.
EDCs are exogenous chemicals that are able to interfere
with the endogenous endocrine system. Due to their ubiq-
uitous presence in the environment, it has been suggested
that exposure to EDCs may result in adverse health effects.
It has been shown that alkylphenols, a widespread group of
EDCs, bind to estrogen receptors (ERs) [3] and accumulate
in the body due to their lipophilic properties and long half-
lives [4]. Because estrogen plays an important role in the
development and function of immune cells, alkylphenols
could disturb immune regulation through their actions on
ER-expressing immune cells [5e7]. Accumulating in vitro
data suggest that alkylphenols may promote allergic
responses, partly through ERs. Therefore, in this article, we
review recent advances in our understanding of the effects
of alkylphenol on key cell types and discuss its relevance to
allergic inflammation.
Introduction to alkylphenols: chemistry, use,
and exposure
Two widespread alkylphenols are 4-nonylphenol (NP) and 4-
octylphenol (OP) (Fig. 1), which originate from the aerobic
biodegradation of alkylphenol polyethoxylates (APEOs).
APEOs are widely used as non-ionic surfactants in cleaning,
washing, surface-active, and foaming agents. Thus, prod-
ucts containing APEOs include cosmetics, cleaning prod-
ucts, nonagricultural pesticides, and office products such as
correction fluid and ink [8e10].
NP and OP originate from APEOs that have been used in
sewage treatment applications. They typically accumulate
and persist in sewage sludge and river sediments. In addi-
tion to their presence in soil, river water, and ground water,
alkylphenols have also been found in many kinds of food-
stuffs [11], even baby foods [12]. Thus, the intake of
contaminated water and foods is considered one of the
major routes of exposure [11,13]. An in vivo rat toxicologyFigure 1. Chemical structuresstudy reported that ingested alkylphenols can be absorbed,
metabolized, and eliminated within 24 hours of exposure
[14]. However, due to their low solubility and high hydro-
phobicity, alkylphenols still tend to accumulate in the
human body. As shown in Table 1 [4,15e18], alkylphenols
are detectable in both adipose tissue and breast milk,
which contain high concentrations of fat. The frequency of
detection of NP in different samples is usually higher than
that of OP. NP is also present at higher concentrations
compared with OP, which may result from the more
frequent use and higher hydrophobicity of NP [19]. These
studies suggest that chronic exposure to alkylphenols,
especially NP, from contaminated foodstuffs results in its
accumulation in the human body.Estrogenicity of alkylphenols
Several studies have shown that alkylphenols have estro-
genic effects on marine and freshwater species. In in vitro
mammalian studies, NP and OP demonstrate relatively
weak affinities (approximately 0.05% and 0.02% affinity for
17-b-estradiol, respectively) to ERa and ERb based on
saturation ligand-binding analysis [3] and bioassays using
reporter gene constructs of various cell lines [20]. However,
these assays are not able to distinguish between ER agonists
and antagonists. In addition, they do not predict tissue-
specific estrogenic or anti-estrogenic activities. The most
well-known estrogenic compound is tamoxifen, a drug that
is widely used for the treatment and prevention of breast
cancer. Tamoxifen demonstrates moderate ER affinity and
anti-estrogenic effects in breast tumors, but demonstrates
estrogenic activities in other tissues such as bone, the
uterus, and the vascular system [21,22]. Thus, alkylphenols
may alter immune responses because estrogen is able to
regulate the functions of immune cells, such as dendritic
cells (DC) [5,6] and T cells [7]. However, the estrogenic and
anti-estrogenic effects of alkylphenols needs to be further
clarified.of estradiol and alkylphenol.
Table 1 Reported burden of alkylphenols in human samples.
Sample Alkylphenol level N (%)a Location Study
Human milk NP: 4.47 4.31b ng/g (mean) 59 (86%) Taiwan [18]
OP: 1.29 1.68b ng/g (mean) 59 (31%)
Adipose tissue NP: 57 (10e567)c ng/g (median) 20 (100% ) Spain [4]
OP: 4.5 (ndee8.6)c ng/g (median) 20 (23.5%)
Urine NP: 0.1 (nde1.6)d mg/L (median) 371 (51%) USA [15]
OP: 0.3 (nde0.4)d mg/L (median) 2517 (57%) [17]
Maternal plasma NP: 5.68 (nde268)c ng/g (median) 42 (52.4%) Taiwan [16]
Umbilical cord plasma NP: 2.95 (nde100)c ng/g (median) 42 (52.4%) Taiwan [16]
a Number of patients (%).
b Mean standard deviation.
c Median (min e max).
d Median (95% confidence interval).
e ndZ not detected.
Effect of alkylphenols on the allergic response S45Effect of alkylphenols on the mucosal
epithelium
Allergic asthma is a chronic inflammatory disease of the
airway. It is characterized by eosinophilic inflammation,
mucus hypersecretion, and bronchial hyperreactivity that
are triggered by the inhalation of allergens [23]. It has
been well demonstrated that T helper 2 (Th2) cells play
an important role in the initiation and maintenance of
asthma. Cytokines, such as IL-4, IL-5, and IL-13, are
secreted by Th2 cells to stimulate endothelial cells to
express adhesion molecules and chemokines that recruit
inflammatory cells to the site of inflammation. In addi-
tion, these cytokines drive IgE production by promoting
immunoglobulin class-switch recombination in allergen-
specific B cells. Upon exposure to an allergen, the
cross-linkage of effector cell-bound IgE by the allergens
leads to the release of biologically active mediators,
such as histamine and leukotrienes. These mediators
induce acute inflammatory and allergic responses
(Fig. 2) [24].
Environmental factors may also influence the function
of the mucosal epithelium in order to promote the
subsequent development of the Th2 response. For
example, Der p 1, the major house/dust mite allergen
with protease activities, can directly reduce epithelial
barrier function [25]. Local basophils can be activated by
exogenous proteases to release thymic stromal lympho-
protein (TSLP), which can significantly promote allergic
inflammation [26,27]. A recent study demonstrated that
NP can induce human bronchial epithelial cell lines to
undergo apoptosis via the Fas/FasL apoptotic pathway
[28]. In addition, mediators collected from NP-treated
bronchial epithelial cell lines stimulate primary bron-
chial smooth muscle cells to proliferate and migrate
in vitro. The important mediators involved in the effects
of NP include IL-6 and IL-8 [28]. Because epithelial
damage is crucial to the initiation of lung inflammation
and smooth muscle hyperplasia (i.e., proliferation),
a cardinal feature of pulmonary fibrosis, this study
suggests that NP may participate in the pathogenesis of
allergic diseases through its ability in modulation of the
epithelium and smooth muscle cells.Effect of alkylphenols on myeloid DC
Myeloid DCs are another key regulatory cell that links
innate and adaptive immunities and plays an important
role in the development of allergic diseases. It has the
ability to modulate immune responses, including antigen
presentation, cytokine secretion, naı¨ve T cell activation,
and T cell differentiation [29]. Immature DCs take up
allergens in the airway lumen, then these activated DCs
mature and migrate to the local lymph nodes where they
present peptides derived from the allergen to the context
of MHC class II molecules and naı¨ve CD4þ T cells. These
cells further differentiate into Th2 cells that are mediated
by DCs (Fig. 2) [30]. In the presence of IL-4 and IL-13
(which are secreted by Th2) and the ligation of Notch-
Jagged, allergen-specific B cells undergo immunoglobulin
class-switching and secrete the IgE antibody. Myeloid DCs
also produce proinflammatory cytokines, such as TNF-a and
IL-6. These cytokines have many pleiotropic activities
and play important roles in the pathogenesis of allergic
diseases [31].
Alkylphenols may modulate the functions of antigen-
presenting cells (APCs), such as DCs. An in vitro study
reported that naı¨ve CD4þ T cells can be induced to differ-
entiate into the Th2 cells by several kinds of EDCs, most
particularlyOP [32]. Theeffect ofOPonTh2polarizationmay
be through its activities in the suppression and augmentation
of IL-12 and IL-10 from splenic APCs, respectively. This study
also demonstrates that exposure to another EDC, tributyltin
chloride, effectively exacerbates airway inflammation in
a murine model of allergic asthma [32]. However, the
particular subset of APCs that are involved inOP’s effectswas
not identified in that study. Recently, another in vitro study
on human circulating myeloid DCs reported that both NP and
OP can enhance proinflammatory activities in DCs via
epigenetic regulation [33]. This study also suggests that
alkylphenols may increase TNF-a expression in DCs, at least
in part, through ER andMKK3/6-p38MAPK signaling pathways
[33]. In addition, alkylphenol-treated DCs demonstrated
histone modification at the TNF-a gene locus. This suggests
that alkylphenols may act on DCs through genomic and non-
genomic effects, potentially leading to dysregulated
immune responses.
Figure 2. Allergen-induced airway inflammation. Allergens are taken up and processed by local DCs in the airway lumen or
submucosal area. Activated DCs present the peptide-MHC class II complex to naı¨ve CD4þ T cells in the regional lymph nodes. In the
presence of the appropriate signals, such as IL-4 or Jagged, naı¨ve CD4þ T cells are further differentiated into the Th2 phenotype.
Th2 cells secrete IL-4 and IL-13 to promote IgE production from allergen-specific B cells. The high-affinity receptor for IgE (Fc 3RI),
which is expressed by mast cells, binds with allergen-specific IgE. After re-exposure to the allergen, recognition of the allergen and
binding to IgE induces Fc 3RI aggregation, which activates mast cells to secrete preformed mediators and synthesize cytokines.
Preformed mediators result in bronchoconstriction, vasodilation, mucus secretion, and increased vascular permeability. The
synthesized cytokines contribute to late-phase inflammation through the influx of inflammatory cells, such as eosinophils, baso-
phils, and lymphocytes.
S46 J.-L. Suen et al.Effect of alkylphenols on mast cells
IgE-sensitized mast cells are key effectors of allergic
inflammation. The recognition of a particular allergen by
Fc 3RI-bound IgE activates tissue mast cells to undergo
degranulation. Activated mast cells rapidly secrete pre-
formed lipid mediators and increase the synthesis of
different cytokines, chemokines, and growth factors. The
rapidly secreted mediators, including histamine, prosta-
glandin, and leukotriene, result in bronchoconstriction,
vasodilation, and increased vascular permeability (Fig. 2).
These mediators contribute to the late-phase reaction by
promoting the infiltration of inflammatory leukocytes,
including eosinophils and lymphocytes. In addition, several
mediators derived from mast cells also influence the func-
tions of structural cells, such as epithelial cells, fibroblasts,
smooth muscle cells, and vascular endothelial cells. Thus,
mast cell degranulation is a key process that mediates
allergic inflammation.
Alkylphenols may influence mast cell degranulation.
Narita et al. [34] demonstrates that NP and other environ-
mental estrogens induce mast cell degranulation in either
an IgE- or IgE-independent manner. Also, like estrogen (E2),
the concentration-response curve of NP during mast cell
degranulation is an inverted U-shaped (biphasic) curve. The
effect of NP is, at least in part, meditated via ER-a in ER-a-
deficient bone marrow-derived mast cells (BMMCs), sug-
gesting the involvement of other unrecognized receptors.This study suggests that environmental estrogens, like NP,
may enhance the severity of allergic diseases by promoting
the degranulation of mast cells.Effect of alkylphenols on antigen-primed mice
in vivo
An in vivo study demonstrated that intraperitoneal OP
exposure enhances keyhole limpet hemocyanin (KLH)-
induced IL-4 secretion from T cells and serum IgE in
antigen-immunized mice [35]. The effect of OP on IL-4
production can be inhibited by FK506, a calcineurin inhib-
itor, but not by ER antagonist ICI-182780. This study
suggests that alkylphenols, in particular OP, may promote
Th2 differentiation in vivo, at least in part, via the
enhancement of IL-4 production by T cells. However, this
study does not clarify the effect of OP on Th1 differentia-
tion, its cytokine pattern, or other immunoglobulin
subclasses. It is unclear as to whether OP is truly indicative
of Th2 responses, or a pan-immunomodulator that
enhances the overall immune response. In addition, when
attempting to estimate the impact of alkylphenols on
human allergic diseases based on allergic responses in
mice, the appropriate EDC exposure level and the route of
exposure need to be considered in the disease model, as
human beings usually receive daily low-level exposure to
alkylphenols via the oral route.
Table 2 In vitro effects of alkylphenols on immune cells.
Chemical Exposure (optimal
concentration)
Species and cell type Exposure effects Reference
NP 107e104 M Human BEAS-2Ba and
HBE135-E6E7a; BSMCb
NP induces apoptosis in bronchial epithelial cell lines; NP
stimulates bronchial epithelial cell lines to secrete IL-6
and IL-8, leading to bronchial smooth muscle proliferation
and migration
[28]
OP 109e104 M (105 M) Splenic CD4þ T cell
and APC (C57BL/6)
OP significantly promotes Th2 differentiation through
the modulation of APC function in an IL-10-dependent
manner.
[32]
NP/OP 1010e107 M Human circulating
myeloid DCs
Alkylphenols increase TNF-a but suppress IL-10 expression







NP enhances IgE-mediated degranulation through, at least
in part, ERa;
NP and E2 demonstrate additive effects on degranulation.
[34]
a human bronchial epithelial cell line.
b BSMC, human primary bronchial smooth muscle cell.
c BMMC, bone marrow-derived mast cell.
d HMC-1, human mast cell line.
Effect of alkylphenols on the allergic response S47Conclusion
Although direct human health data regarding the associa-
tion between alkylphenols and allergic diseases are
unavailable, these in vitro studies (Table 2) and one in vivo
study suggest that alkylphenol exposure may influence the
onset, progression, and severity of allergic diseases
through their actions on key cell types, either via an ER-
dependent or -independent pathway. However, the causal
relationship and the mechanistic link between alkylphenol
exposure and the expression of allergic diseases need to be
further addressed. The causal relationship should be
established after considering the relevant route and level
of exposure in humans. Finally, the association between
alkylphenol exposure and the exacerbation of human
allergic diseases, such as asthma, should be further
investigated.
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